Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer
Luis Javier Martínez-González, Victor Sánchez-Conde, Jose María González-Cabezuelo, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 646-646
Open Access | Times Cited: 17

Showing 17 citing articles:

Explainable artificial intelligence to predict and identify prostate cancer tissue by gene expression
Alberto Ramírez-Mena, Eduardo Andrés‐León, María Jesús Álvarez-Cubero, et al.
Computer Methods and Programs in Biomedicine (2023) Vol. 240, pp. 107719-107719
Open Access | Times Cited: 27
Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes
Mohammed Saqif Ahmad, Maria Braoudaki, Hershna Patel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review
José Pedro Sequeira, Sofia Salta, Rui Freitas, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1363-1363
Open Access | Times Cited: 4
Unveiling hotspots of emerging research in the miRNA-related mechanism underlying cancer through comprehensive bibliometric analysis with implications for precision medicine and non-invasive diagnostics
Zhirui Zhang, Wenwei Song, Wenyu Chen, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer
Xing‐Yu Zhong, Yuxuan Yang, Hao‐Dong He, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases
Agnieszka Bielska, Anna Skwarska, Adam Krętowski, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1553-1553
Open Access | Times Cited: 16
m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer
Yingchun Liang, Xiaohua Zhang, Chenkai Ma, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4035-4035
Open Access | Times Cited: 10
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!
Ghada Chamandi, Layal El‐Hajjar, Abdallah Kurdi, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2300-2300
Open Access | Times Cited: 5
Oncogenic MicroRNAs: Key players in human prostate cancer pathogenesis, a narrative review
Ali Moradi, Unes Sahebi, Hamid Nazarian, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Closed Access | Times Cited: 1
Guava seed polysaccharides ameliorate the inflammatory status in PC-3 xenograft mice
Hsiao-Chien Lin, Jin‐Yuarn Lin
Food Hydrocolloids for Health (2022) Vol. 2, pp. 100068-100068
Open Access | Times Cited: 7
miR-145-5p: A Potential Biomarker in Predicting Gleason Upgrading of Prostate Biopsy Samples Scored 3+3=6
Tao Wang, Lei Dong, Juanjuan Sun, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 9095-9106
Open Access | Times Cited: 8
Diagnostic and Prognostic Value of miR-93 in Prostate Cancer: A Meta-Analysis and Bioinformatics Analysis
Hassane Gazzaz, M. Habchi, Mohammed El Feniche, et al.
Iranian Journal of Public Health (2023)
Open Access | Times Cited: 2
The clinical diagnostic value of plasma miR-592 and miR-217-3p levels in retinoblastoma
Luo Yan, Lin Huang, Hu Yu, et al.
Journal of Medical Biochemistry (2022) Vol. 41, Iss. 4, pp. 497-505
Open Access | Times Cited: 4
Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs
Eva Slabáková, Zuzana Kahounová, Jiřina Procházková, et al.
Non-Coding RNA (2021) Vol. 7, Iss. 4, pp. 75-75
Open Access | Times Cited: 5
Osteo-immunomodulatory effects of macrophage-derived extracellular vesicles treated with biphasic calcium phosphate ceramics on bone regeneration
Fuying Chen, Jiajun Liu, Keting Liu, et al.
Biomedical Materials (2024) Vol. 19, Iss. 4, pp. 045025-045025
Closed Access
Molecular Perspectives on Prostate Cancer: The Role of microRNAs in Androgen Receptor Regulation
Asbiel Felipe Garibaldi-Ríos, Alicia Rivera-Cameras, Luis E. Figuera, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 494-512
Open Access
The Clinical Usefulness of Prostate Cancer Biomarkers: Current and Future Directions
Donovan McGrowder, Lennox Anderson-Jackson, Lowell Dilworth, et al.
Biomedical engineering (2022)
Open Access | Times Cited: 1
Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network
Jinling Li, Hongyuan Yu, Jinlong Yao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 1
Page 1

Scroll to top